CVS Health Corporation stockholders approved the 2026 Incentive Compensation Plan and the ratification of Ernst & Young LLP as the company's independent auditor at the 2026 Annual Meeting. A stockholder proposal to reduce the threshold for the right to act by written consent was defeated, receiving 417,969,177 votes in favor and 617,361,014 votes against.

CVS Health Corporation issued a press release on May 6, 2026, announcing its financial results for the three months ended March 31, 2026.

CVS Health Corporation has elected John E. Gallina to its Board of Directors, effective March 19, 2026. Mr. Gallina, the former Executive Vice President and CFO of Elevance Health, will also serve on the company's Audit Committee as a designated audit committee financial expert.

CVS Health Corporation issued a press release on February 10, 2026, announcing its financial results for the three months and full year ended December 31, 2025. The specific financial figures and performance details are contained in the accompanying press release furnished as Exhibit 99.1.

CVS Health Corporation issued a press release during its 2025 Investor Day to outline strategic priorities and update its financial outlook. The company updated its full-year 2025 financial guidance and provided new full-year financial guidance for 2026.